Han Han

发表

A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy

Haiquan Chen, Han Han, Yue Zhao, 2019, Journal of Cancer Research and Clinical Oncology.

Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part solid or solid lesions.

Yang Zhang, Haiquan Chen, Zhexu Wen, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.

Jing Wang, Kwok-Kin Wong, J. Heymach, 2019, Cancer cell.

Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma

Leming Shi, Zhiwei Cao, Haiquan Chen, 2022, Frontiers in Immunology.

Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer

Haiquan Chen, Zhexu Wen, Yuan Li, 2021, Journal of Cancer Research and Clinical Oncology.

Pan-cancer landscape and functional analysis of ERBB2 mutations identifies poziotinib as a clinically active inhibitor and enhancer of T-DM1 activity

Hu, Shuai, Alexa, 2020 .

NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma

Haiquan Chen, Han Han, Yue Zhao, 2021, Journal of Cancer Research and Clinical Oncology.

Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

Kwok-Kin Wong, V. Velcheti, Hsin-Yi Huang, 2022, Journal for ImmunoTherapy of Cancer.

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.

H. Ji, A. Bass, A. Moreira, 2022, Cancer cell.

Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis

Kwok-Kin Wong, V. Velcheti, Haiquan Chen, 2020, Journal of the National Cancer Institute.

Recent advances in preclinical models for lung squamous cell carcinoma

Kwok-Kin Wong, Yuanwang Pan, Han Han, 2021, Oncogene.

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Kwok-Kin Wong, Haiquan Chen, C. Peng, 2021, Cancer Research.

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

D. Schadendorf, B. Ueberheide, Ting Chen, 2021, Cancer Immunology Research.

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.

Jing Wang, Kwok-Kin Wong, V. Miller, 2020, Cancer cell.

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer

C. Perou, C. Rudin, G. Freeman, 2021, Nature Cancer.

Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC

Kwok-Kin Wong, B. Neel, J. Christensen, 2021, bioRxiv.

Evolutionary Action Score of TP53 enhances the prognostic prediction for stage I lung adenocarcinoma.

Haiquan Chen, Han Han, Yue Zhao, 2020, Seminars in thoracic and cardiovascular surgery.

Genomic and immune profiling of pre-invasive lung adenocarcinoma

Joshua D. Campbell, Lindsay C. Westlake, Ashton C. Berger, 2019, Nature Communications.

Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer

Haiquan Chen, Zhexu Wen, Shengping Wang, 2021, Translational lung cancer research.

Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer

G. Freeman, Kwok-Kin Wong, Haiquan Chen, 2022, Science advances.

Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy

Kwok-Kin Wong, Haiquan Chen, Zhexu Wen, 2020, Journal of Cancer Research and Clinical Oncology.

Uniportal versus multiportal video-assisted thoracoscopic anatomical resection for NSCLC: a meta-analysis

Haiquan Chen, Han Han, Qingyuan Huang, 2020, Journal of Cardiothoracic Surgery.

Title : Targeting HER 2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel 2 Tyrosine Kinase Inhibitor

Kwok-Kin Wong, Haiquan Chen, V. Rivera, 2021 .

CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.

Dayanne M. Castro, Richard Bonneau, G. Freeman, 2019, Cancer cell.

Selective versus systematic lymph node dissection (other than sampling) for clinical N2-negative non-small cell lung cancer: a meta-analysis of observational studies.

Haiquan Chen, Han Han, Yue Zhao, 2018, Journal of thoracic disease.

Subsolid lesions exceeding 3 centimeters: the ground-glass opacity component still matters.

Haiquan Chen, Zhexu Wen, Shengping Wang, 2021, The Annals of thoracic surgery.

Selective lymph node dissection in early-stage non-small cell lung cancer.

Haiquan Chen, Han Han, 2017, Journal of thoracic disease.

A tumor microenvironment-related mRNA–ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma

Haiquan Chen, Han Han, Yue Zhao, 2021, Journal of Cancer Research and Clinical Oncology.

Uniportal versus multiportal video-assisted thoracoscopic surgery for non-small cell lung cancer: a meta-analysis

Haiquan Chen, Han Han, Qingyuan Huang, 2020 .

Development and validation of a five‐gene model to predict postoperative brain metastasis in operable lung adenocarcinoma

Haiquan Chen, Zhexu Wen, Yuan Li, 2020, International journal of cancer.

Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma

Zhiwei Cao, Haiquan Chen, Han Han, 2023, Cancer research.

Clinicopathologic features, concurrent genomic alterations, and clinical outcomes of patients with KRAS G12D mutations in resected lung adenocarcinoma.

Han Han, Yang Zhang, Zelin Ma, 2024, European journal of cancer.

Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.

Yuan Li, Han Han, F. Fu, 2023, Cell reports. Medicine.

Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages

Yuan Li, Han Han, F. Fu, 2024, Nature communications.